NCT01274338
Clinical Trial Information
Trial Number: NCT01274338 (ClinicalTrials.gov)
Disease Type:
- Skin Neoplasm - Melanoma
Trial Title:
A Phase III Randomized Study of Adjuvant Ipilimumab Anti-CTLA4 Therapy Versus High-Dose Interferon Alfa-2b for Resected High-risk Melanoma
Study ID:
E1609
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®